Virios Therapeutics Inc (VIRI)
0.2183
+0.01
(+5.36%)
USD |
NASDAQ |
May 31, 16:00
0.2174
0.00 (0.00%)
After-Hours: 20:00
Virios Therapeutics Shareholders Equity (Quarterly): 2.654M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.654M |
| December 31, 2023 | 3.807M |
| September 30, 2023 | 4.762M |
| June 30, 2023 | 4.692M |
| March 31, 2023 | 5.971M |
| December 31, 2022 | 7.326M |
| September 30, 2022 | 9.225M |
| June 30, 2022 | 7.142M |
| March 31, 2022 | 10.67M |
| Date | Value |
|---|---|
| December 31, 2021 | 14.50M |
| September 30, 2021 | 18.88M |
| June 30, 2021 | 22.86M |
| March 31, 2021 | 27.11M |
| December 31, 2020 | 29.94M |
| September 30, 2020 | -5.150M |
| June 30, 2020 | -6.064M |
| December 31, 2019 | -4.942M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-6.064M
Minimum
Jun 2020
29.94M
Maximum
Dec 2020
9.023M
Average
7.142M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 4.826M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.225M |
| Total Liabilities (Quarterly) | 0.5701M |